Neurovascular regulation in the normal brain and in Alzheimer's disease

被引:0
|
作者
Costantino Iadecola
机构
[1] Weill Medical College of Cornell University,Division of Neurobiology
[2] room KB410,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The rate of cerebral blood flow (CBF) is positively correlated with brain activity. This 'functional hyperaemia' is mediated by the coordinated action of various vasoactive agents — including ions that are associated with synaptic transmission and some neurotransmitters — on blood vessels.The increases in CBF that are associated with neural activity are spatially restricted to the site of activity. Local interneurons and astrocytes are probably crucial to regulation of CBF at this level, producing and releasing vasoactive mediators.Vasodilation of extracerebral arteries that supply the site of neural activity is probably achieved through the upstream transmission of vasoactive signals within the walls of blood vessels.The 'neurovascular unit' — a functional entity comprising neurons, astrocytes, smooth muscle cells and endothelial cells — has a key role in the haemodynamic response to brain activity.Disruption of this regulatory network occurs in response to brain injury; for example, during stroke. Evidence now indicates that cerebrovascular dysfunction is a feature of neurodegenerative disorders such as Alzheimer's disease.Accumulation of amyloid β-peptide (Aβ) in brain is associated with neuronal death in Alzheimer's disease. Aβ induces dysfunction in all cell types of the neurovascular unit and interferes with the function of blood vessels. These effects are mediated through reactive oxygen species.
引用
收藏
页码:347 / 360
页数:13
相关论文
共 50 条
  • [21] Neurovascular and neurometabolic derailment in aging and Alzheimer's disease
    Lourenco, Catia F.
    Ledo, Ana
    Dias, Candida
    Barbosa, Rui M.
    Laranjinha, Joao
    FRONTIERS IN AGING NEUROSCIENCE, 2015, 7
  • [22] Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease
    Nelson, Amy R.
    Sweeney, Melanie D.
    Sagare, Abhay P.
    Zlokovic, Berislav V.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2016, 1862 (05): : 887 - 900
  • [23] Cooperation between neurovascular dysfunction and Aβ in Alzheimer's disease
    Wang, Niya
    Yang, Xiang
    Zhao, Zhong
    Liu, Da
    Wang, Xiaoyan
    Tang, Hao
    Zhong, Chuyu
    Chen, Xinzhang
    Chen, Wenli
    Meng, Qiang
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2023, 16
  • [24] Impact of Tau on Neurovascular Pathology in Alzheimer's Disease
    Canepa, Elisa
    Fossati, Silvia
    FRONTIERS IN NEUROLOGY, 2021, 11
  • [25] Brain imaging evidence of preclinical Alzheimer's disease in normal aging
    Jagust, W
    Gitcho, A
    Sun, F
    Kuczynski, B
    Mungas, D
    Haan, M
    ANNALS OF NEUROLOGY, 2006, 59 (04) : 673 - 681
  • [26] Aneuploidy and DNA replication in the normal human brain and Alzheimer's disease
    Mosch, Birgit
    Morawski, Markus
    Mittag, Anja
    Lenz, Dominik
    Tarnok, Attila
    Arendt, Thomas
    JOURNAL OF NEUROSCIENCE, 2007, 27 (26): : 6859 - 6867
  • [27] THE HUMAN BRAIN: THE PATH FROM NORMAL AGING TO ALZHEIMER'S DISEASE
    Bouras, Constantin
    NEUROBIOLOGY OF AGING, 2016, 39 : S11 - S11
  • [28] Expression of the kallikrein gene family in normal and Alzheimer's disease brain
    Shimizu-Okabe, C
    Yousef, GM
    Diamandis, EP
    Yoshida, S
    Shiosaka, S
    Fahnestock, M
    NEUROREPORT, 2001, 12 (12) : 2747 - 2751
  • [29] Topography of brain atrophy during normal aging and Alzheimer's disease
    Double, KL
    Halliday, GM
    Kril, JJ
    Harasty, JA
    Cullen, K
    Brooks, WS
    Creasey, H
    Broe, GA
    NEUROBIOLOGY OF AGING, 1996, 17 (04) : 513 - 521
  • [30] The challenge of characterizing normal brain aging in relation to Alzheimer's disease
    Morris, JC
    NEUROBIOLOGY OF AGING, 1997, 18 (04) : 388 - 389